Lam Research (LRCX)
(Real Time Quote from BATS)
$967.94 USD
-2.63 (-0.27%)
Updated May 28, 2024 10:42 AM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Lam Research Corporation falls in the month of June.
All items in Millions except Per Share data.
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 5,375 | 3,658 | 5,729 | 6,710 | 5,431 |
Receivables | 2,823 | 4,314 | 3,026 | 2,097 | 1,456 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4,816 | 3,966 | 2,689 | 1,900 | 1,540 |
Other Current Assets | 214 | 347 | 208 | 146 | 134 |
Total Current Assets | 13,228 | 12,285 | 11,652 | 10,854 | 8,560 |
Net Property & Equipment | 1,857 | 1,648 | 1,303 | 1,072 | 1,059 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,791 | 1,617 | 1,623 | 1,653 | 1,702 |
Deposits & Other Assets | 1,906 | 1,646 | 1,314 | 981 | 680 |
Total Assets | 18,782 | 17,196 | 15,892 | 14,559 | 12,001 |
Liabilities & Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 471 | 1,011 | 830 | 592 | 377 |
Current Portion Long-Term Debt | 8 | 7 | 11 | 840 | 667 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2,011 | 1,974 | 1,719 | 1,273 | 947 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1,695 | 1,572 | 967 | 458 | 381 |
Total Current Liabilities | 4,185 | 4,565 | 3,528 | 3,162 | 2,372 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 5,003 | 4,998 | 4,990 | 4,971 | 3,823 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,383 | 1,354 | 1,347 | 1,242 | 1,084 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 10,571 | 10,917 | 9,865 | 9,376 | 7,278 |
Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 7,809 | 7,415 | 7,053 | 6,696 | 6,409 |
Retained Earnings | 22,032 | 18,455 | 14,685 | 11,521 | 9,931 |
Other Equity | -101 | -110 | -64 | -83 | -15 |
Treasury Stock | 21,530 | 19,481 | 15,647 | 12,950 | 11,603 |
Total Shareholder's Equity | 8,210 | 6,278 | 6,027 | 5,183 | 4,723 |
Total Liabilities & Shareholder's Equity | 18,782 | 17,196 | 15,892 | 14,559 | 12,001 |
Total Common Equity | 8,210 | 6,278 | 6,027 | 5,183 | 4,723 |
Shares Outstanding | 134.30 | 138.70 | 142.60 | 145.10 | 149.90 |
Book Value Per Share | 61.13 | 45.27 | 42.27 | 35.72 | 31.51 |
Fiscal Year End for Lam Research Corporation falls in the month of June.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 5,672 | 5,638 | 5,157 | 5,375 | 5,370 |
Receivables | 2,204 | 2,707 | 2,811 | 2,823 | 3,262 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4,323 | 4,430 | 4,748 | 4,816 | 4,882 |
Other Current Assets | 290 | 279 | 278 | 214 | 216 |
Total Current Assets | 12,488 | 13,055 | 12,994 | 13,228 | 13,730 |
Net Property & Equipment | 2,182 | 2,147 | 2,111 | 1,857 | 1,855 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,769 | 1,778 | 1,784 | 1,791 | 1,802 |
Deposits & Other Assets | 1,840 | 1,804 | 1,650 | 1,906 | 1,856 |
Total Assets | 18,280 | 18,784 | 18,538 | 18,782 | 19,243 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 532 | 500 | 528 | 471 | 602 |
Current Portion Long-Term Debt | 505 | 4 | 4 | 8 | 8 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,792 | 1,976 | 2,120 | 2,011 | 1,990 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1,602 | 1,793 | 1,595 | 1,695 | 1,841 |
Total Current Liabilities | 4,430 | 4,272 | 4,247 | 4,185 | 4,441 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,478 | 4,980 | 4,980 | 5,003 | 4,997 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,349 | 1,263 | 1,383 | 1,398 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 10,258 | 10,561 | 10,491 | 10,571 | 10,836 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 8,082 | 7,997 | 7,879 | 7,809 | 7,680 |
Retained Earnings | 24,052 | 23,347 | 22,655 | 22,032 | 21,460 |
Other Equity | -128 | -118 | -121 | -101 | -105 |
Treasury Stock | 23,985 | 23,004 | 22,366 | 21,530 | 20,628 |
Total Shareholder's Equity | 8,022 | 8,222 | 8,047 | 8,210 | 8,407 |
Total Liabilities & Shareholder's Equity | 18,280 | 18,784 | 18,538 | 18,782 | 19,243 |
Total Common Equity | 8,022 | 8,222 | 8,047 | 8,210 | 8,407 |
Shares Outstanding | 130.70 | 131.10 | 131.70 | 134.30 | 134.30 |
Book Value Per Share | 61.38 | 62.72 | 61.10 | 61.13 | 62.60 |